(ISSN 2573-4393)
OBM Integrative and Complementary Medicine is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. It covers all evidence-based scientific studies on integrative, alternative and complementary approaches to improving health and wellness.
Topics contain but are not limited to:
The journal publishes a variety of article types: Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.
There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.9 weeks; Submission to Acceptance: 14.7 weeks; Acceptance to Publication: 8 days (1-2 days of FREE language polishing included)
Special Issue
Evidence-Based Application of Natural Products in the Prevention and Treatment of Diseases
Submission Deadline: March 31, 2025 (Open) Submit Now
Guest Editor
Bashar Saad, PhD, Full Professor
1.Faculties of Medicine, Arab American University, P.O. Box 240, Jenin, State of Palestine
2.Al-Qasemi Research Center, Al-Qasemi Academy, P.O. Box 124, Baqa El-Gharbia 30100, Israel
Research interests: cancer research; medicinal plants; inflammation; Metabolism
About This Topic
Herbal-based diet and medicines, which are a type of natural product, combine traditional medical practices and generations of therapeutic wisdom. They offer invaluable advice on how to select, prepare, and apply herbal formulations for the treatment of various ailments. These plant-based remedies have been effectively used to treat conditions such as skin diseases, tuberculosis, diabetes, jaundice, hypertension, mental disorders, cancer, AIDS, and other infectious diseases. The World Health Organization (WHO) reports that 60% of the global population depends on herbal medicine, with about 80% of people in developing countries relying almost entirely on it for their primary health care needs. Phytochemicals and their chemical analogs have yielded numerous clinically useful drugs for treating chronic and acute diseases, and research continues to seek new therapeutic agents from medicinal plants. The growing popularity and acceptance of herbal medicine is due to the belief that natural products are safe, affordable, and readily available. However, there are concerns about the pharmacognosy and standardization of herbal medicine compared to conventional drugs. Over the past three decades, research efforts have increased in both developed and developing countries to scientifically evaluate and validate herbal drugs through clinical trials.
The aim of this Special Issue is to collate original research articles addressing the efficiency of active ingredients or extracts from natural products for the management of diabesity and its complications. Review articles discussing the state of the art are also welcome. Potential topics include but are not limited to the following:
- Evidence-based herbal medicine is used for promoting health and managing human diseases.
- The structure-activity relationship of pharmacologically active metabolites plays a crucial role in various types of diseases, such as obesity, diabetes, cardiovascular diseases, and inflammation.
- Honey and its products are used for the prevention and management of diseases.
- Pharmaceutical formulations of pharmacologically active metabolites are effective in managing chronic diseases.
- Different pharmacologically active metabolites are used in the management of chronic diseases.
- Recent advances in drug discovery have identified potential anti-cardiovascular, anti-diabetic, and anti-obesity compounds from the Mediterranean diet and medicinal plants.
- Identifying the cellular targets of effective natural products is a key step in drug discovery.
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (icm@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
- Newsletter